{"id":"vedolizumab-sc","brandName":"Vedolizumab SC","genericName":"Vedolizumab SC","companyId":"takeda","companyName":"Takeda","phase":"marketed","status":"active","modality":"Small molecule","aliases":["MLN0002SC","MLN0002","ENTYVIO, KYNTELES, MLN0002","Entyvio","MLN0002, ENTYVIO, KYNTELES"],"developmentCodes":[],"firstApprovalDate":null,"firstApprovalCountry":null,"aiSummary":"Vedolizumab SC, developed by Takeda, is a monoclonal antibody targeting gut-specific inflammation. It is currently in Phase 3 and 4 trials for ulcerative colitis and Crohn's disease, with a strong safety profile and promising efficacy. The drug is not yet FDA-approved but has several ongoing and completed trials.","enrichmentLevel":3,"visitCount":0,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"By binding to α4β7 integrin expressed on memory T cells, vedolizumab prevents these cells from adhering to mucosal addressin cell adhesion molecule-1 (MAdCAM-1) on gut endothelial cells. This blocks lymphocyte trafficking to the intestinal mucosa, reducing local inflammation in inflammatory bowel disease. The subcutaneous formulation (SC) provides an alternative to intravenous administration with improved patient convenience.","oneSentence":"Vedolizumab is a monoclonal antibody that selectively blocks the α4β7 integrin on gut-homing lymphocytes, preventing their migration to the gastrointestinal tract.","_ai_confidence":"high"},"administration":{},"safety":{"commonSideEffects":[{"rate":null,"effect":"Nasopharyngitis"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Arthralgia"},{"rate":null,"effect":"Pyrexia"},{"rate":null,"effect":"Injection site reactions"}]},"trials":[],"indications":{"approved":[{"name":"Ulcerative colitis (induction and maintenance of remission)"},{"name":"Crohn's disease (induction and maintenance of remission)"}]},"commercial":null,"patents":[],"timeline":[],"rwe":[],"competitors":[],"ownershipHistory":[],"trialDetails":[],"genericFilers":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"labelChanges":[],"nice":null,"revenue":null,"trialStats":{"total":5,"withResults":5},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":false,"score":3}}